Join
Live feed
·
INSIDERFilingvia Quantisnow
Dicerna Pharmaceuticals, Inc. logo

SEC Form 4: Weissman James B sold $147,071 worth of Common Stock (4,904 units at $29.99), decreasing direct ownership by 23% to 16,000 units

ByQuantisnow·Wall Street's wire, on your screen.
DRNA· Dicerna Pharmaceuticals, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DRNA (Dicerna Pharmaceuticals, Inc.) and more on Quantisnow.